Reproducibility and genital sparing with a vaginal dilator used for female anal cancer patients

Radiotherapy and Oncology

Volumn 104, Issue 2, 2012, Pages 161-166

  Briere, Tina Marie ^a   Crane, Christopher H ^a   Beddar, Sam ^a   Bhosale, Priya ^a   Mok, Henry ^a   Delclos, Marc E ^a   Krishnan, Sunil ^a   Das, Prajnan ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Anal cancer; Squamous cell carcinoma; Vaginal dilator

Indexed keywords

SILICONE;

ANUS CANCER; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONE BEAM COMPUTED TOMOGRAPHY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MEDICAL DEVICE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION FIELD; RADIATION PROTECTION; REPRODUCIBILITY; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; VAGINAL DILATOR;

AGED; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CONE-BEAM COMPUTED TOMOGRAPHY; DILATATION; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; GENITALIA, FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIATION DOSAGE; RADIATION INJURIES; RADIATION PROTECTION; RADIOTHERAPY, INTENSITY-MODULATED; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SAMPLING STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VAGINA;

EID: 84865754000     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.05.011     Document Type: Article

References (20)

1. UKCCCR Anal Cancer Trial Working Party Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin Lancet 348 1996 1049 1054
2. M. Flam, M. John, and T.F. Pajak Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study J Clin Oncol 14 1996 2527 2539
3. H. Bartelink, F. Roelofsen, and F. Eschwege Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups J Clin Oncol 15 1997 2040 2049
4. J.A. Ajani, K.A. Winter, and L.L. Gunderson Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial Jama 299 2008 1914 1921
5. A.S. Allal, M.A. Sprangers, F. Laurencet, M.A. Reymond, and J.M. Kurtz Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy Br J Cancer 80 1999 1588 1594
6. D. Vordermark, M. Sailer, M. Flentje, A. Thiede, and O. Kolbl Curative-intent radiation therapy in anal carcinoma: quality of life and sphincter function Radiother Oncol 52 1999 239 243
7. C.R. Jephcott, C. Paltiel, and J. Hay Quality of life after non-surgical treatment of anal carcinoma: a case control study of long-term survivors Clin Oncol (R Coll Radiol) 16 2004 530 535
8. L. Tournier-Rangeard, M. Mercier, and D. Peiffert Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03) Radiother Oncol 87 2008 391 397
9. K. Saarilahti, P. Arponen, L. Vaalavirta, and M. Tenhunen The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer Radiother Oncol 87 2008 383 390
10. P. Das, S.B. Cantor, and C.L. Parker Long-term quality of life after radiotherapy for the treatment of anal cancer Cancer 116 2010 822 829
11. J.K. Salama, L.K. Mell, and D.A. Schomas Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience J Clin Oncol 25 2007 4581 4586
12. L. Kachnic, K. Winter, and R. Myerson RTOG 0529: a phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for reduction of acute morbidity in carcinoma of the anal canal Int J Radiat Oncol Biol Phys 75 2009 S5
13. L. Kachnic, K. Winter, and R. Myerson Early efficacy results of RTOG 0529: a phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal Int J Radiat Oncol Biol Phys 78 2010 S55
14. J.M. Pepek, C.G. Willett, Q.J. Wu, S. Yoo, R.W. Clough, and B.G. Czito Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis Int J Radiat Oncol Biol Phys 78 2010 1413 1419
15. J.G. Bazan, W. Hara, and A. Hsu Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal Cancer 2011 3342 3351
16. L.A. Kachnic, H.K. Tsai, and J.J. Coen Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy Int J Radiat Oncol Biol Phys 82 2012 153 158
17. Y.J. Chen, A. Liu, and P.T. Tsai Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes Int J Radiat Oncol Biol Phys 63 2005 274 281
18. M.T. Milano, A.B. Jani, K.J. Farrey, C. Rash, R. Heimann, and S.J. Chmura Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome Int J Radiat Oncol Biol Phys 63 2005 354 361
19. H. Mok, T.M. Briere, and M.K. Martel Comparative analysis of volumetric modulated arc therapy versus intensity modulated radiation therapy for radiotherapy of anal carcinoma Prac Radiat Oncol 1 2011 163 172
20. H. Ikushima, P. Balter, and R. Komaki Daily alignment results of in-room computed tomography-guided stereotactic body radiation therapy for lung cancer Int J Radiat Oncol Biol Phys 79 2011 473 480